1. Home
  2. AUR vs MDGL Comparison

AUR vs MDGL Comparison

Compare AUR & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$7.08

Market Cap

14.2B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$516.96

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUR
MDGL
Founded
2017
2011
Country
United States
United States
Employees
1900
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
11.5B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
AUR
MDGL
Price
$7.08
$516.96
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$9.43
$674.45
AVG Volume (30 Days)
29.5M
264.2K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.32
EPS
N/A
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$407.30
$58.39
Revenue Next Year
$1,134.58
$48.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$265.00
52 Week High
$8.57
$615.00

Technical Indicators

Market Signals
Indicator
AUR
MDGL
Relative Strength Index (RSI) 57.84 51.29
Support Level $5.17 $498.34
Resistance Level $8.57 $554.40
Average True Range (ATR) 0.55 23.54
MACD -0.09 -1.47
Stochastic Oscillator 30.00 41.89

Price Performance

Historical Comparison
AUR
MDGL

About AUR Aurora Innovation Inc.

Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: